EcoDrugPlus

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSEEUG00000015100
Gene Symbol: ADRM1
4 External references
261 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSEEUG00000012805
Gene Symbol: AKT1
1 External references
220 Possible Orthologues:

Akt Serine/threonine Kinase 2

Ensembl ID : ENSEEUG00000013220
Gene Symbol: AKT2
1 External references
257 Possible Orthologues:

Akt Serine/threonine Kinase 3

Ensembl ID : ENSEEUG00000005774
Gene Symbol: AKT3
1 External references
201 Possible Orthologues:

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSEEUG00000007119
Gene Symbol: ABCB1
1 External references
161 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSEEUG00000014938
Gene Symbol: ABCC1
1 External references
203 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 8

Ensembl ID : ENSEEUG00000013037
Gene Symbol: ABCC8
1 External references
245 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 9

Ensembl ID : ENSEEUG00000003075
Gene Symbol: ABCC9
1 External references
231 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSEEUG00000003276
Gene Symbol: ATP1A1
1 External references
328 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2

Ensembl ID : ENSEEUG00000006918
Gene Symbol: ATP1A2
1 External references
207 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 3

Ensembl ID : ENSEEUG00000008547
Gene Symbol: ATP1A3
3 External references
134 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSEEUG00000005272
Gene Symbol: ATP1B1
1 External references
290 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).